FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2971337387> ?p ?o ?g. }

• W2971337387 abstract "Ovarian carcinomas are the deadliest gynecological malignancies owing to their high rate of recurrence and high resistance to platinum-based chemotherapy. Recent studies have shown platinum-dependent enrichment of ovarian tumors with side population as well as cancer stem cells, which are highly resistant to the treatment. To overcome this treatment-limiting factor, we sought to combine cisplatin with eugenol, a natural substance known to have anti-cancer effects.The efficiency of combining cisplatin with eugenol was first tested in vitro on two ovarian cancer cell lines SKOV3 and OV2774 using the WST1 and the flow cytometry techniques. The effect of this combination on ovarian cancer stem cells was determined by the tumorsphere formation assay, while the implication of the Notch pathway was evaluated post-ectopic expression of the Hes1 gene. The resulting changes in the expression of several markers was assessed by immunoblotting, immunofluorescence as well as quantitative RT-PCR. Cell sorting was also used to isolate specific ovarian cancer sub-population of cells. Furthermore, tumor-bearing mouse models were utilized to prove the potential therapeutic value of the cisplatin/eugenol combination treatment in vivo.We have shown that adding eugenol to cisplatin-treated ovarian cancer cells synergistically inhibited their growth and survival through induction of apoptosis. Importantly, this sequential inhibition strongly reduced the proportion of side population cells and suppressed cisplatin-dependent enrichment in ovarian cancer stem cells. Additionally, while increase in the level of Hes1 promoted stemness and enhanced resistance to cisplatin, cisplatin/eugenol cotreatment inhibited the Notch-Hes1 pathway and strongly downregulated the drug resistance ABC transporter genes. These findings were confirmed in vivo by showing that cisplatin/eugenol cotherapy inhibited tumor growth in animals, reduced the proportion and self-renewal capacities of cancer stem cells and significantly improved disease-free survival of tumor-bearing animals compared with either therapy alone.These results indicate that cisplatin/eugenol sequential combination could be of great therapeutic value for ovarian cancer patients through targeting the Notch-Hes1 pathway and the consequent elimination of the resistant cancer stem cells." @default.
• W2971337387 created "2019-09-05" @default.
• W2971337387 creator A5027854700 @default.
• W2971337387 creator A5038471270 @default.
• W2971337387 date "2019-08-30" @default.
• W2971337387 modified "2023-10-18" @default.
• W2971337387 title "Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway" @default.
• W2971337387 cites W1507366824 @default.
• W2971337387 cites W1602048773 @default.
• W2971337387 cites W1904460196 @default.
• W2971337387 cites W1975527793 @default.
• W2971337387 cites W1998258610 @default.
• W2971337387 cites W2000420730 @default.
• W2971337387 cites W2004419844 @default.
• W2971337387 cites W2004915963 @default.
• W2971337387 cites W2030200135 @default.
• W2971337387 cites W2035233698 @default.
• W2971337387 cites W2051960191 @default.
• W2971337387 cites W2067067209 @default.
• W2971337387 cites W2078284356 @default.
• W2971337387 cites W2098076875 @default.
• W2971337387 cites W2103562758 @default.
• W2971337387 cites W2107400278 @default.
• W2971337387 cites W2111923995 @default.
• W2971337387 cites W2123696077 @default.
• W2971337387 cites W2147373929 @default.
• W2971337387 cites W2156131378 @default.
• W2971337387 cites W2159515687 @default.
• W2971337387 cites W2167960944 @default.
• W2971337387 cites W2169384017 @default.
• W2971337387 cites W2170233592 @default.
• W2971337387 cites W2277854123 @default.
• W2971337387 cites W2399911066 @default.
• W2971337387 cites W2411664241 @default.
• W2971337387 cites W2570618306 @default.
• W2971337387 cites W2766754213 @default.
• W2971337387 cites W2772038399 @default.
• W2971337387 cites W2777052697 @default.
• W2971337387 cites W2785608148 @default.
• W2971337387 cites W2889028749 @default.
• W2971337387 cites W2889761777 @default.
• W2971337387 cites W4235054326 @default.
• W2971337387 doi "https://doi.org/10.1186/s13046-019-1360-3" @default.
• W2971337387 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6716935" @default.
• W2971337387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31470883" @default.
• W2971337387 hasPublicationYear "2019" @default.
• W2971337387 type Work @default.
• W2971337387 sameAs 2971337387 @default.
• W2971337387 citedByCount "40" @default.
• W2971337387 countsByYear W29713373872020 @default.
• W2971337387 countsByYear W29713373872021 @default.
• W2971337387 countsByYear W29713373872022 @default.
• W2971337387 countsByYear W29713373872023 @default.
• W2971337387 crossrefType "journal-article" @default.
• W2971337387 hasAuthorship W2971337387A5027854700 @default.
• W2971337387 hasAuthorship W2971337387A5038471270 @default.
• W2971337387 hasBestOaLocation W29713373871 @default.
• W2971337387 hasConcept C121608353 @default.
• W2971337387 hasConcept C126322002 @default.
• W2971337387 hasConcept C136302470 @default.
• W2971337387 hasConcept C161879069 @default.
• W2971337387 hasConcept C2776694085 @default.
• W2971337387 hasConcept C2778239845 @default.
• W2971337387 hasConcept C2780283210 @default.
• W2971337387 hasConcept C2780427987 @default.
• W2971337387 hasConcept C2780546549 @default.
• W2971337387 hasConcept C28328180 @default.
• W2971337387 hasConcept C2908647359 @default.
• W2971337387 hasConcept C502942594 @default.
• W2971337387 hasConcept C55427017 @default.
• W2971337387 hasConcept C62478195 @default.
• W2971337387 hasConcept C71924100 @default.
• W2971337387 hasConcept C86803240 @default.
• W2971337387 hasConcept C95444343 @default.
• W2971337387 hasConcept C99454951 @default.
• W2971337387 hasConceptScore W2971337387C121608353 @default.
• W2971337387 hasConceptScore W2971337387C126322002 @default.
• W2971337387 hasConceptScore W2971337387C136302470 @default.
• W2971337387 hasConceptScore W2971337387C161879069 @default.
• W2971337387 hasConceptScore W2971337387C2776694085 @default.
• W2971337387 hasConceptScore W2971337387C2778239845 @default.
• W2971337387 hasConceptScore W2971337387C2780283210 @default.
• W2971337387 hasConceptScore W2971337387C2780427987 @default.
• W2971337387 hasConceptScore W2971337387C2780546549 @default.
• W2971337387 hasConceptScore W2971337387C28328180 @default.
• W2971337387 hasConceptScore W2971337387C2908647359 @default.
• W2971337387 hasConceptScore W2971337387C502942594 @default.
• W2971337387 hasConceptScore W2971337387C55427017 @default.
• W2971337387 hasConceptScore W2971337387C62478195 @default.
• W2971337387 hasConceptScore W2971337387C71924100 @default.
• W2971337387 hasConceptScore W2971337387C86803240 @default.
• W2971337387 hasConceptScore W2971337387C95444343 @default.
• W2971337387 hasConceptScore W2971337387C99454951 @default.
• W2971337387 hasIssue "1" @default.
• W2971337387 hasLocation W29713373871 @default.
• W2971337387 hasLocation W29713373872 @default.
• W2971337387 hasLocation W29713373873 @default.
• W2971337387 hasLocation W29713373874 @default.
• W2971337387 hasOpenAccess W2971337387 @default.
• W2971337387 hasPrimaryLocation W29713373871 @default.

• next